Ticker > Company >

NGL Fine-Chem share price

NGL Fine-Chem Ltd.

NSE: NGLFINE BSE: 524774 SECTOR: Pharmaceuticals & Drugs  52.96 K   256   41

2188.25
+364.70 (20.00%)
BSE: Today, 11:56 AM

Price Summary

Today's High

₹ 2188.25

Today's Low

₹ 1920

52 Week High

₹ 2031.05

52 Week Low

₹ 962.7

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1351.91 Cr.

Enterprise Value

1422.3 Cr.

No. of Shares

0.62 Cr.

P/E

45.43

P/B

4.6

Face Value

₹ 5

Div. Yield

0.1 %

Book Value (TTM)

₹  475.82

CASH

5.73 Cr.

DEBT

76.12 Cr.

Promoter Holding

72.74 %

EPS (TTM)

₹  48.17

Sales Growth

9.22%

ROE

6.69 %

ROCE

8.29%

Profit Growth

-52.93 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year9.22%
3 Year4.08%
5 Year18.75%

Profit Growth

1 Year-53.37%
3 Year-30.02%
5 Year11.49%

ROE%

1 Year6.69%
3 Year10.59%
5 Year20.77%

ROCE %

1 Year8.29%
3 Year12.91%
5 Year25.07%

Debt/Equity

0.2722

Price to Cash Flow

79.45

Interest Cover Ratio

8.5149

CFO/PAT (5 Yr. Avg.)

0.55522852115768

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2025 72.74 0.00
Sep 2025 72.74 0.00
Jun 2025 72.74 0.00
Mar 2025 72.74 0.00
Dec 2024 72.74 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has a healthy Interest coverage ratio of 8.5149.
  • The company has an efficient Cash Conversion Cycle of 29.3886 days.
  • Company has a healthy liquidity position with current ratio of 2.0058.
  • The company has a high promoter holding of 72.74%.

 Limitations

  • The company has shown a poor profit growth of -29.7257580825604% for the Past 3 years.
  • The company has shown a poor revenue growth of 4.08074705501629% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 86.83 93.02 100.86 116.84 126.33
Total Expenditure 83.28 89.11 93.04 103.18 106.24
Operating Profit 3.55 3.91 7.82 13.66 20.09
Other Income 0.15 -0.79 6.55 2.41 4.69
Interest 0.6 0.95 1.21 1.15 1.06
Depreciation 2.3 2.53 3.45 4.26 4.35
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.81 -0.36 9.72 10.66 19.37
Tax 0.03 0.16 2.07 2.76 4.64
Profit After Tax 0.78 -0.52 7.65 7.9 14.74
Adjusted EPS (Rs) 1.27 -0.84 12.37 12.78 23.85

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 258.18 318.67 275.05 328.97 359.29
Total Expenditure 181.13 252.75 246.34 284.21 332.72
Operating Profit 77.05 65.92 28.71 44.76 26.57
Other Income 8.55 12.64 7.61 15.9 9.76
Interest 2.2 1.91 1.83 1.8 3.18
Depreciation 7.39 7.67 7.9 8.15 9.27
Exceptional Items 0 0 0 0 0
Profit Before Tax 76 68.97 26.6 50.71 23.88
Tax 20.53 16.73 6.48 12.19 5.75
Net Profit 55.33 52.19 20.04 38.37 17.89
Adjusted EPS (Rs.) 89.79 84.57 32.57 62.35 29.35

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 3.09 3.09 3.09 3.09 3.09
Total Reserves 152.36 203.48 222.43 259.72 276.52
Borrowings 6.13 3.44 2.07 0.74 25.34
Other N/C liabilities 5 4.6 3.87 5.13 6.21
Current liabilities 39.21 63.12 56.65 84.36 114.61
Total Liabilities 205.8 277.72 288.11 353.05 425.76
Assets
Net Block 57.53 58.68 59.49 60.13 119.89
Capital WIP 0.91 6.31 26.31 45.52 49.73
Intangible WIP 0 0 0 0 0
Investments 3.73 3.73 3.73 3.73 3.73
Loans & Advances 20.17 36.4 35.01 35.36 21.43
Other N/C Assets 0 2.57 4.39 4.62 1.12
Current Assets 123.47 170.04 159.19 203.69 229.87
Total Assets 205.8 277.72 288.11 353.05 425.76
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 76 68.97 26.6 50.71 23.88
Adjustment 3.25 6.63 5.91 -1.12 8.7
Changes in Assets & Liabilities -32.15 -43.06 5.86 -26.26 -9.82
Tax Paid -20.53 -16.73 -6.48 -12.19 -5.75
Operating Cash Flow 26.57 15.82 31.89 11.14 17.02
Investing Cash Flow -23.79 -16.13 -23.62 -17.49 -15.75
Financing Cash Flow -1.08 -1.08 -1.08 -1.08 -1.08
Net Cash Flow 1.71 -1.4 7.19 -7.44 0.19

Corporate Actions

Investors Details

PARTICULARS Dec 2024% Mar 2025% Jun 2025% Sep 2025% Dec 2025%
promoters 72.74 72.74 72.74 72.74 72.74
ajita nachane 11.55 11.55 11.55 11.55 11.55
pci ferrmone chemicals (i... 8.38 8.38 - - 8.38
rahul nachane 17.54 17.54 17.54 17.54 17.54
rajesh lawande 21.89 21.89 21.89 21.89 21.89
sunita potdar 13.38 13.38 13.38 13.38 13.38
pci ferrmone chemicals (i... - - - 8.38 -
pci ferrmone chemicals (i... - - 8.38 - -
PARTICULARS Dec 2024% Mar 2025% Jun 2025% Sep 2025% Dec 2025%
investors 27.26 27.26 27.26 27.26 27.26
llp 0.04 0.04 0.04 0.04 0.04
yashkumar poonamchand gol... - 1.05 - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit ICRA
Credit CRISIL
Credit ICRA
Credit ICRA
Credit ICRA
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY26
Concall Q2FY24
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY22
Presentation Q4FY21
Presentation Q4FY21
Presentation Q3FY24
Presentation Q3FY23
Presentation Q3FY22
Presentation Q2FY24
Presentation Q2FY23
Presentation Q2FY22
Presentation Q1FY25
Presentation Q1FY22

Company News

NGL Fine-Chem informs about certificate 3 Jan, 1:12 PM NGL Fine-Chem - Quaterly Results 1 Aug, 8:08 PM NGL Fine-Chem - Quaterly Results 1 Aug, 8:08 PM NGL Fine-Chem submits BRSR 25 Jul, 5:17 PM NGL Fine Chem informs about compliance certificate 10 Jul, 6:15 PM NGL Fine-Chem informs about credit rating 27 Jun, 12:33 PM NGL Fine-Chem - Quaterly Results 22 May, 8:07 PM NGL Fine-Chem - Quaterly Results 22 May, 8:07 PM NGL Fine Chem informs about disclosure 19 Apr, 4:25 PM Ngl Fine-Chem informs about credit rating 6 Mar, 4:45 PM NGL Fine-Chem informs about outcome of board meeting 6 Mar, 12:37 PM NGL Fine-Chem informs about newspaper publication 10 Feb, 5:14 PM NGL Fine-Chem - Quaterly Results 7 Feb, 7:33 PM NGL Fine-Chem - Quaterly Results 7 Feb, 7:33 PM Ngl Fine-Chem informs about updates 6 Jan, 5:25 PM Ngl Fine-Chem informs about disclosure 23 Sep, 5:21 PM NGL Fine-Chem informs about disclosure 19 Aug, 12:59 PM NGL Fine-Chem informs about newspaper publication 16 Aug, 5:37 PM NGL Fine-Chem - Quaterly Results 12 Aug, 7:09 PM NGL Fine-Chem - Quaterly Results 12 Aug, 7:09 PM Ngl Fine-Chem informs about disclosure 18 Jun, 6:06 PM NGL Fine-Chem submits analyst meet outcome 1 Jun, 3:54 PM NGL Fine-Chem informs about revised investor presentation 28 May, 3:31 PM NGL Fine-Chem - Quaterly Results 21 May, 8:08 PM NGL Fine-Chem - Quaterly Results 21 May, 8:08 PM NGL Fine-Chem informs about issuance of letter of confirmation 2 May, 5:29 PM NGL Fine-Chem submits postal ballot notice 19 Mar, 11:08 AM NGL Fine-Chem informs about board meeting 11 Mar, 5:09 PM NGL Fine-Chem - Quaterly Results 12 Feb, 7:04 PM NGL Fine-Chem - Quaterly Results 12 Feb, 7:04 PM NGL Fine-Chem informs about board meeting 3 Feb, 11:54 AM Ngl Fine-Chem informs about loss of share certificate 16 Jan, 5:25 PM NGL Fine-Chem informs about issuance of letter of confirmation 1 Jan, 12:22 PM NGL Fine-Chem informs about investor presentation 17 Nov, 2:25 PM NGL Fine-Chem - Quaterly Results 10 Nov, 6:57 PM Ngl Fine-Chem informs about investor meet 8 Nov, 4:30 PM NGL Fine-Chem informs about closure of trading window 28 Sep, 2:35 PM NGL Fine-Chem informs about disclosure 18 Sep, 10:27 AM NGL Fine-Chem informs about disclosure 13 Sep, 2:02 PM NGL Fine-Chem informs about disclosure 11 Sep, 1:16 PM NGL Fine-Chem informs about disclosure 8 Sep, 5:20 PM NGL Fine-Chem - Quaterly Results 4 Aug, 7:17 PM NGL Fine-Chem - Quaterly Results 4 Aug, 7:17 PM NGL Fine-Chem informs about details of loss of certificate 28 Jul, 4:29 PM NGL Fine-Chem informs about credit rating 18 Jul, 2:19 PM NGL Fine-Chem informs about closure of trading window 28 Jun, 4:40 PM NGL Fine-Chem informs about details of loss of certificate 6 Jun, 12:31 PM NGL Fine-Chem - Quaterly Results 15 May, 6:24 PM NGL Fine-Chem - Quaterly Results 15 May, 6:24 PM NGL Fine-Chem informs about conference call 12 May, 3:31 PM

NGL Fine-Chem Stock Price Analysis and Quick Research Report. Is NGL Fine-Chem an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse NGL Fine-Chem. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). NGL Fine-Chem has a PE ratio of 70.4971347712899 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. NGL Fine-Chem has ROA of 4.6563% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. NGL Fine-Chem has a Current ratio of 2.0058.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. NGL Fine-Chem has a ROE of 6.6856%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. NGL Fine-Chem has a Debt to Equity ratio of 0.2722 which means that the company has low proportion of debt in its capital.

  • Sales growth: NGL Fine-Chem has reported revenue growth of 9.2167% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of NGL Fine-Chem for the current financial year is 7.39545803082994%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for NGL Fine-Chem is Rs 1.75 and the yield is 0.096%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of NGL Fine-Chem is Rs 25.5826. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of NGL Fine-Chem in Ticker for free. Also, one can get the intrinsic value of NGL Fine-Chem by using Valuation Calculators, which are available with a Finology ONE subscription. 

NGL Fine-Chem FAQs

Q1. What is NGL Fine-Chem share price today?
Ans: The current share price of NGL Fine-Chem is Rs 1803.5.

Q2. What is the market capitalisation of NGL Fine-Chem?
Ans: NGL Fine-Chem has a market capitalisation of Rs 1114.2066284 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of NGL Fine-Chem?
Ans: The PE ratio of NGL Fine-Chem is 70.4971347712899 and the P/B ratio of NGL Fine-Chem is 3.79028212434858, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of NGL Fine-Chem share?
Ans: The 52-week high share price of NGL Fine-Chem is Rs 2050, and the 52-week low share price of NGL Fine-Chem is Rs 957.

Q5. Does NGL Fine-Chem pay dividends?
Ans: Currently, NGL Fine-Chem pays dividends. Dividend yield of NGL Fine-Chem is around 0.096%.

Q6. What are the face value and book value of NGL Fine-Chem shares?
Ans: The face value of NGL Fine-Chem shares is Rs 5, while the book value per share of NGL Fine-Chem is around Rs 475.8221. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of NGL Fine-Chem?
Ans: NGL Fine-Chem has a total debt of Rs 76.1229 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of NGL Fine-Chem?
Ans: The ROE of NGL Fine-Chem is 6.6856% and ROCE of NGL Fine-Chem is 8.2938%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is NGL Fine-Chem a good buy for the long term?
Ans: The NGL Fine-Chem long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is NGL Fine-Chem undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the NGL Fine-Chem appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check NGL Fine-Chem’s financials?
Ans: You can review NGL Fine-Chem’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about NGL Fine-Chem
X